Address:  2405 North Fraser Street
                    Georgetown, SC 29442
     Phone:    (843) 545-5600

    • Visit the Georgetown Hospital System website

    • Get directions to Georgetown Hospital System

Participation in the following CTN Cooperative Group studies:

CTO #100899 - NSABP B-39: Breast Program
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs. Partial Breast Irradiation (PBI) for Women with Stage 0,I, or II Breast Cancer

CTO #101185 - ECOG 5202: Gastorintestinal Program
A Randomized Phase III Study Comparing 5-FU, Leucovorin, and Oxaliplatin Vs. 5-FU, Leucovorin, Oxaliplatin, and Bevacizumab in Patients with Stage II Colon Cancer at High Risk to Determine Prospectively to Prognostic value of Molecular Markers

CTO #101186 - CALGB C80405: Gastrointestinal Program
A Phase II Trial of Irinotecan, 5FU, Leucovorin or Oxaliplatin, 5FU, Leucovorin with Bevacizumab or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Color or Rectum

CTO 101243 - CALGB 30610/RTOG 0538: Thoracic Program
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide

CTO #101293 - NSABP B-42: Breast Program                                                                                  A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Post-Menopausal Women with Hormone Receptor Positive Breast Cancer